"The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis.
Simponi works by blocking tumor necrosis factor (TNF), which plays an important"...
- Patient Information:
Details with Side Effects
Patients with Phenylketonuria
- Inform patients with phenylketonuria (PKU) or their caregivers that each APRISO (mesalamine extended-release capsules) capsule contains aspartame equivalent to 0.56 mg of phenylalanine, so that the recommended adult dosing provides an equivalent of 2.24 mg of phenylalanine per day.
General Counseling Information
- Instruct patients not to take APRISO (mesalamine extended-release capsules) capsules with antacids, because it could affect the way APRISO (mesalamine extended-release capsules) dissolves.
- Instruct patients to contact a health care provider if they experience a worsening of ulcerative colitis symptoms, because it could be due to a reaction to APRISO (mesalamine extended-release capsules) .
Last reviewed on RxList: 9/14/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Apriso Information
Apriso - User Reviews
Apriso User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.